Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
GSK PLC
GSK
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.














| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | GSK PLC GSK | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | AstraZeneca AZN Depositary Shares | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Eli Lilly LLY | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Pfizer PFE Pfizer, Inc. | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | R RHHBY | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Merck MRK Stock | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Johnson & Johnson JNJ | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Johnson & Johnson JNJ | Mar 3, 2025 44 days to disclose | Good buy·+$3.1K+38.3% +39.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Merck MRK Stock | Mar 3, 2025 44 days to disclose | Good buy·+$1.8K+21.9% +22.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Pfizer PFE Pfizer, Inc. | Mar 3, 2025 44 days to disclose | Good buy·+$85+1.1% +1.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | R RHHBY | Mar 3, 2025 44 days to disclose | Good buy·+$1.9K+23.4% +24.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | AstraZeneca AZN Depositary Shares | Mar 3, 2025 44 days to disclose | Good buy·+$1.7K+21.5% +22.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Eli Lilly LLY | Mar 3, 2025 44 days to disclose | Good buy·+$1.1K+13.5% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | GSK PLC GSK | Mar 3, 2025 44 days to disclose | Good buy·+$2.7K+33.1% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |